FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $15.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-06-30 was $15.32, a 130.72% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $25.96, a 310.11% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-09-30 was $12.61, a 94.30% increase year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $6.64, a 49.89% decline year-over-year.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $7.39, a 48.14% decline from fiscal 2024.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $14.25, a 13.16% decline from fiscal 2023.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $16.41, a 1703.30% increase from fiscal 2022.
- FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $0.91.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.32 10-Q · filed 2026-08-12 | $20.95 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | $25.96 10-Q · filed 2026-05-11 | |||||||
| 2025-12-31 | $7.39 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | $12.61 10-Q · filed 2025-11-14 | $6.67 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | $6.64 10-Q · filed 2026-08-12 | $6.36 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | $6.33 10-Q · filed 2026-05-11 | |||||||
| 2024-12-31 | $14.25 10-K · filed 2026-03-31 | |||||||
| 2024-09-30 | $6.49 10-Q · filed 2025-11-14 | $14.25 10-Q · filed 2025-11-14 | ||||||
| 2024-06-30 | $13.25 10-Q · filed 2025-08-14 | $0.53 10-Q · filed 2024-08-14 | $15.50 10-Q · filed 2025-08-14 | $0.62 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $15.66 10-Q · filed 2025-05-15 | $0.63 10-Q · filed 2024-05-13 | ||||||
| 2023-12-31 | $16.41 10-K · filed 2025-03-28 | $0.66 10-K · filed 2024-03-18 | ||||||
| 2023-09-30 | $16.98 10-Q · filed 2024-11-14 | $0.69 10-Q · filed 2023-11-13 | $17.76 10-Q · filed 2024-11-14 | $0.71 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $0.81 10-Q · filed 2024-08-14 | $0.81 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | $0.82 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | $0.91 10-K · filed 2024-03-18 | |||||||
| 2022-09-30 | $0.92 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | $0.82 10-Q · filed 2023-08-14 | $0.92 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $0.96 10-Q · filed 2023-05-15 | |||||||
| 2021-09-30 | $18.49 10-Q · filed 2022-11-14 | $21.89 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | $23.40 10-Q · filed 2022-08-15 | $23.29 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | $22.89 10-Q · filed 2022-05-16 | |||||||
| 2020-09-30 | $13.34 10-Q · filed 2021-11-08 | $10.30 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | $10.08 10-Q · filed 2021-08-16 | $16.53 10-Q · filed 2020-08-10 | $8.17 10-Q · filed 2021-08-16 | $13.39 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | $0.16 10-Q · filed 2021-05-10 |